ZA882353B - Human tumour-associated antigen - Google Patents

Human tumour-associated antigen

Info

Publication number
ZA882353B
ZA882353B ZA882353A ZA882353A ZA882353B ZA 882353 B ZA882353 B ZA 882353B ZA 882353 A ZA882353 A ZA 882353A ZA 882353 A ZA882353 A ZA 882353A ZA 882353 B ZA882353 B ZA 882353B
Authority
ZA
South Africa
Prior art keywords
associated antigen
human tumour
tumour
human
antigen
Prior art date
Application number
ZA882353A
Other languages
English (en)
Inventor
Christian Jensenius Per Borup-Christensen Jens
Erb Karin
Original Assignee
Christian Jensenius Per Borup-Christensen Jens
Erb Karin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian Jensenius Per Borup-Christensen Jens, Erb Karin filed Critical Christian Jensenius Per Borup-Christensen Jens
Publication of ZA882353B publication Critical patent/ZA882353B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA882353A 1987-04-03 1988-03-31 Human tumour-associated antigen ZA882353B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK169987A DK169987D0 (da) 1987-04-03 1987-04-03 Human tumor-associated antigen, ca-ou1

Publications (1)

Publication Number Publication Date
ZA882353B true ZA882353B (en) 1988-09-23

Family

ID=8107312

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882353A ZA882353B (en) 1987-04-03 1988-03-31 Human tumour-associated antigen

Country Status (14)

Country Link
US (1) US5338661A (xx)
EP (1) EP0285173B1 (xx)
JP (1) JPH082920B2 (xx)
KR (1) KR890700358A (xx)
AU (1) AU618260B2 (xx)
DE (1) DE3884646T2 (xx)
DK (1) DK169987D0 (xx)
ES (1) ES2059418T3 (xx)
FI (1) FI894650A (xx)
IE (1) IE60993B1 (xx)
IL (1) IL85955A (xx)
NZ (1) NZ224156A (xx)
WO (1) WO1988007377A1 (xx)
ZA (1) ZA882353B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619226B2 (en) * 1987-09-28 1992-01-23 Children's Hospital Medical Center Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods
US5118611A (en) * 1988-07-25 1992-06-02 Adeza Biomedical Corporation Adenocarcinoma antigen binding methods and reagents
CA2015862A1 (en) * 1989-05-04 1990-11-04 Gajanan Nilaver Cell surface antigen that binds with l6 monoclonal antibody
WO1993015405A1 (en) * 1992-01-29 1993-08-05 Sci-Clone, Inc. Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor
US5834215A (en) * 1994-10-05 1998-11-10 The Administrators Of The Tulane Educational Fund Method for detecting antipolymer antibodies and diagnosing silicone related disease (SRD) fibromyalgia and chronic fatigue syndrome (CFS)
US5744585A (en) * 1995-03-16 1998-04-28 Medenica; Rajko D. Human monoclonal antibody against lung carcinoma
US6288215B1 (en) * 1996-08-30 2001-09-11 Auburn University Monoclonal antibodies specific to cooked meats
AU4094297A (en) * 1996-08-30 1998-03-19 Auburn University Monoclonal antibodies specific to cooked meats
US20020127584A1 (en) * 1997-09-18 2002-09-12 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP4406206B2 (ja) * 2001-04-24 2010-01-27 バイエル コーポレーション ヒトｔｉｍｐ−１抗体
WO2003024191A2 (en) * 2001-09-21 2003-03-27 Raven Biotechnologies, Inc. Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof
AU2003207459A1 (en) * 2002-01-03 2003-07-24 The Scripps Research Institute Cancer-associated epitope

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
GR850552B (xx) * 1984-03-07 1985-07-05 Du Pont
US4761377A (en) * 1984-10-15 1988-08-02 The Regents Of The University Of California Human-human hybrid cell lines that produce antibodies against antigenic determinants on cancer cells
ES8800604A1 (es) * 1985-04-22 1987-11-16 Hybritech Inc Un metodo para producir anticuerpos monoclonales
NO861491L (no) * 1985-04-22 1986-10-23 Hybritech Inc Antistoff, fremgangsmaate for dets fremstilling og anvendelse for deteksjon og diagnose av canser.
EP0242154B1 (en) * 1986-04-17 1993-03-03 Hybritech Incorporated A novel tumor-associated antigen

Also Published As

Publication number Publication date
FI894650A0 (fi) 1989-10-02
EP0285173A3 (en) 1990-01-31
US5338661A (en) 1994-08-16
IE60993B1 (en) 1994-09-07
AU1596588A (en) 1988-11-02
ES2059418T3 (es) 1994-11-16
JPH02503383A (ja) 1990-10-18
DE3884646D1 (de) 1993-11-11
EP0285173B1 (en) 1993-10-06
DK169987D0 (da) 1987-04-03
IL85955A0 (en) 1988-09-30
NZ224156A (en) 1991-07-26
FI894650A (fi) 1989-10-02
WO1988007377A1 (en) 1988-10-06
JPH082920B2 (ja) 1996-01-17
AU618260B2 (en) 1991-12-19
DE3884646T2 (de) 1994-01-27
EP0285173A2 (en) 1988-10-05
IL85955A (en) 1994-12-29
KR890700358A (ko) 1989-04-24
IE880976L (en) 1988-10-03

Similar Documents

Publication Publication Date Title
HU906229D0 (en) Medical preparations
EP0300185A3 (en) Wheel-chair
IL81961A0 (en) Forceps
PT86573A (en) Therapeutic preparations
PH23914A (en) Cosmetic
ZA88149B (en) Anti-reproductive vaccines
ZA882353B (en) Human tumour-associated antigen
PH25588A (en) Cosmetics
EP0313641A4 (en) Activation antigen
ZA88646B (en) Shampoo
EP0274696A3 (en) Ambulance
GB8819015D0 (en) Wheelchairs
GB8704647D0 (en) Vaccine
GB8813529D0 (en) Wheelchair
GB8800919D0 (en) Wheelchair
JPS6410000A (en) Human splenine
PL267730A1 (en) Audiometer
IE870468L (en) Human angiogenic factor
PL268581A1 (en) Cosmetic preparation
PL269242A1 (en) Cosmetic preparation
GB8716223D0 (en) Wheelchairs
ZA89370B (en) Stretchers
GB8712685D0 (en) Vaccine
GB8711196D0 (en) Wheelchair
GB8713484D0 (en) Wheelchair